This article only represents the author's own views.
Could tariff fever spread to the pharmaceutical sector? Medicines have been exempted for now from the import tax offensive launched this month by the United States, but drug producers are nervously scrutinizing their options and girding for battle.
A day before U.S. President Donald Trump delivered his “Liberation Day” tariff bombshell on April 2, one of China’s top drug services companies sold off a block of shares in a sister firm specializing in bioconjugate research.
您已閱讀9%（526字），剩餘91%（5611字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。